Rheumatoid Arthritis Clinical Trials in New York

Showing 241-260 of 3,596 trials

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06716138

This is a first-in-human Phase I, multi-center, open-label study of ANS03 in patients with advanced solid tumors. The study evaluates the safety, tolerability, preliminary efficay, pharmacokinetics, anti-tumor activity of ANS03 as monotherapy.

Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

Avistone Biotechnology Co., Ltd.96 participantsStarted Mar 2025

New York, New York, United States • Fuzhou, Fujian, China • Guangzhou, Guangdong, China +2 more locations

COMPLETEDPhase 2< 1 mile

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03196427

The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in pediatric participants with UC or CD.

Ulcerative ColitisCrohn's Disease

Takeda59 participantsStarted Jul 2018

Los Angeles, California, United States • Orange, California, United States • San Francisco, California, United States +20 more locations

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Rheumatoid Arthritis Trials in Other Cities

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Terumo Aortic Global Endovascular Registry

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

Targeting Aging With a Ketone Ester for Function in Frailty

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Other Conditions in New York